Predictive Markers Of Joint Damages Of Children With Systemic-Onset Juvenile Idiopathic Arthritis In Long-Term Course Of Treatment With Tocilizumab

被引：0
|
作者：
Nozawa, Tomo [1 ]
Kanetaka, Taichi [1 ]
Nishimura, Kenichi [1 ]
Kikuchi, Masako [1 ]
Sato, Tomomi [1 ]
Sakurai, Nodoka [1 ]
Hara, Ryoki [1 ]
Yamazaki, Kazuko [1 ]
Yokota, Shumpei [1 ]
机构：
[1] Yokohama City Univ, Sch Med, Yokohama, Kanagawa 232, Japan
来源：
ARTHRITIS AND RHEUMATISM | 2013年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
272
引用
收藏
页码：S113 / S113
页数：1
相关论文
共 50 条
  • [1] OUTCOME OF TOCILIZUMAB THERAPY IN CHILDREN WITH SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS
    Balameena, S.
    Ravichandran, R.
    [J]. JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2018, 7 (23): : 2746 - 2748
  • [2] Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis
    Shumpei Yokota
    Takako Miyamae
    Tomoyuki Imagawa
    Shigeki Katakura
    Rumiko Kurosawa
    Masaaki Mori
    [J]. Clinical Reviews in Allergy & Immunology, 2005, 28 : 231 - 237
  • [3] Clinical study of tocilizumab in children with systemic-onset juvenile idiopathic arthritis
    Yokota, S
    Miyamae, T
    Imagawa, T
    Katakura, S
    Kurosawa, R
    Mori, M
    [J]. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2005, 28 (03) : 231 - 237
  • [4] Systemic-onset juvenile idiopathic arthritis
    Cimaz, Rolando
    [J]. AUTOIMMUNITY REVIEWS, 2016, 15 (09) : 931 - 934
  • [5] Tocilizumab-induced hypofibrinogenemia in patients with systemic-onset juvenile idiopathic arthritis
    Tingyan He
    Jiayun Ling
    Jun Yang
    [J]. Scientific Reports, 13
  • [6] Tocilizumab-induced hypofibrinogenemia in patients with systemic-onset juvenile idiopathic arthritis
    He, Tingyan
    Ling, Jiayun
    Yang, Jun
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [7] Is tocilizumab a good therapeutic option for RA and systemic-onset juvenile idiopathic arthritis?
    Cem Gabay
    [J]. Nature Clinical Practice Rheumatology, 2008, 4 : 572 - 573
  • [8] Is tocilizumab a good therapeutic option for RA and systemic-onset juvenile idiopathic arthritis?
    Gabay, Cem
    [J]. NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2008, 4 (11): : 572 - 573
  • [9] Safety and efficacy of tocilizumab treatment in children with systemic onset of juvenile idiopathic arthritis
    E Alexeeva
    R Denisova
    S Valieva
    T Bzarova
    K Isayeva
    T Sleptsova
    E Mitenko
    [J]. Pediatric Rheumatology, 9 (Suppl 1)
  • [10] Guidelines for diagnosis and treatment in systemic-onset juvenile idiopathic arthritis
    Bader-Meunier, B.
    Wouters, C.
    Job-Deslandre, C.
    Cimaz, R.
    Hofer, M.
    Pillet, P.
    Quartier, P.
    [J]. ARCHIVES DE PEDIATRIE, 2010, 17 (07): : 1090 - 1094
12345